GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Revenue

Magle Chemoswed Holding AB (OSTO:MAGLE) Revenue : kr171.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Revenue?

Magle Chemoswed Holding AB's revenue for the three months ended in Mar. 2024 was kr41.9 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr171.1 Mil. Magle Chemoswed Holding AB's Revenue per Share for the three months ended in Mar. 2024 was kr3.88. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr15.90.

Warning Sign:

Magle Chemoswed Holding AB revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Magle Chemoswed Holding AB was 10.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was -5.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, Magle Chemoswed Holding AB's highest 3-Year average Revenue per Share Growth Rate was 5.80% per year. The lowest was -5.50% per year. And the median was 2.60% per year.


Magle Chemoswed Holding AB Revenue Historical Data

The historical data trend for Magle Chemoswed Holding AB's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB Revenue Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 127.57 142.34 132.15 145.68 170.44

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.21 41.35 40.30 47.58 41.90

Competitive Comparison of Magle Chemoswed Holding AB's Revenue

For the Biotechnology subindustry, Magle Chemoswed Holding AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's Revenue distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's Revenue falls into.



Magle Chemoswed Holding AB Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr171.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB  (OSTO:MAGLE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Magle Chemoswed Holding AB Revenue Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines